KRAS mutations (MTs) in non-small cell lung cancer (NSCLC) versus colorectal cancer (CRC): Implications for cetuximab therapy

被引：0
|
作者：
Danenberg, K. D.
Grimminger, P. P.
Mack, P. C.
Danenberg, P. V.
Cooc, J.
Stephens, C.
Reddy, S. K.
Li, T.
Gandara, D. R.
机构：
[1] Response Genet, Los Angeles, CA USA
[2] Univ Cologne, Dept Gen Visceral & Canc Surg, D-50931 Cologne, Germany
[3] Univ Calif Davis, Sacramento, CA 95817 USA
[4] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA
[5] Harbor UCLA Med Ctr, Los Alamitos, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10529
引用
收藏
页数：1
相关论文
共 50 条
  • [1] KRAS mutation analysis in non-small cell lung cancer (NSCLC) versus colorectal cancer (CRC): implications for EGFR-directed therapies
    Mack, Philip C.
    Gandara, David R.
    Omori, Akiko
    Grimminger, Peter P.
    Lenz, Heinz-Josef
    Joshi, Mary-Beth M.
    Harpole, David H.
    Danenberg, Kathleeen D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S350 - S350
  • [2] Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
    Liu, Stephen, V
    Vanderwalde, Ari M.
    Mamdani, Hirva
    Raez, Luis E.
    Baca, Yasmine
    Xiu, Joanne
    Korn, Wolfgang Michael
    Nagasaka, Misako
    Pai, Sachin Gopalkrishna
    Socinski, Mark A.
    Nieva, Jorge J.
    Kim, Chul
    Wozniak, Antoinette J.
    Ikpeazu, Chukwuemeka
    Lopes, Gilberto
    Spira, Alexander, I
    Judd, Julia
    Kim, Edward S.
    Borghaei, Hossein
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Implications of KRAS Mutations on Outcomes in Non-small Cell Lung Cancer Treated With Radiation Therapy
    Welsh, J. W.
    Likacheva, A.
    Byers, L. A.
    Bhardwaj, V.
    Diao, L.
    Wang, J.
    Ang, K.
    Komaki, R.
    Kim, E.
    Heymach, J. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S70 - S70
  • [4] ANALYSIS OF KRAS MUTATIONS IN NON-SMALL CELL LUNG CANCER (NSCLC) BRAZILIAN PATIENTS
    Couto, Patricia G. P.
    Bastos-rodrigues, Luciana
    Sabato, Cristina
    Guieiro, Fernanda
    Vilhena, Alyne
    Amaral, Nilson F.
    De Marco, Luiz
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S735 - S736
  • [5] Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?
    Sgambato, Assunta
    Casaluce, Francesca
    Maione, Paolo
    Rossi, Antonio
    Ciardiello, Fortunato
    Gridelli, Cesare
    JOURNAL OF THORACIC DISEASE, 2014, 6 (06) : 578 - 580
  • [6] A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC).
    Lynch, TJ
    Lilenbaum, R
    Bonomi, P
    Ansari, R
    Govindan, R
    Janne, PA
    Hanna, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 637S - 637S
  • [7] A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC)
    Hanna, N
    Bonomi, P
    Lynch, T
    Ansari, R
    Govindan, R
    Janne, R
    Lilenbaum, R
    LUNG CANCER, 2005, 49 : S38 - S38
  • [8] Predictive Implications of KRAS and EGFR Gene Mutations in Non-small Cell Lung Cancer Treated with Radiation Therapy
    Likhacheva, A.
    Thomas, J.
    Kim, E.
    Allen, P. K.
    Komaki, R.
    Cox, J.
    Herbst, R.
    Welsh, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S128 - S129
  • [9] Predictive Implications of KRAS and EGFR Gene Mutations in Non-Small Cell Lung Cancer Treated with Radiation Therapy
    Welsh, James
    Likhacheva, Anna
    Kim, Edward
    Allen, Pamela
    Herbst, Roy
    Cox, James
    Komaki, Ritusko
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S381 - S381
  • [10] The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)
    Salgia, Ravi
    Pharaon, Rebecca
    Mambetsariev, Isa
    Nam, Arin
    Sattler, Martin
    CELL REPORTS MEDICINE, 2021, 2 (01)
12345